STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Gross margin
STERIS plc's gross margin over the twelve months to 30 June 2026 was 44.4%, up 0.2 percentage points from fiscal 2026 (44.3%). Over the past ten years it has ranged from 39.3% (fiscal 2017) to 44.6% (fiscal 2022); the current reading is higher than 92% of that period. That is below the Medical Devices industry median of 56.0% and below the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 44.3% | 0.24 |
| FY2025 | 44.0% | 0.85 |
| FY2024 | 43.2% | (0.50) |
| FY2023 | 43.7% | (0.93) |
| FY2022 | 44.6% | 1.37 |
| FY2021 | 43.2% | (0.33) |
| FY2020 | 43.6% | 1.32 |
| FY2019 | 42.2% | 0.52 |
| FY2018 | 41.7% | 2.43 |
| FY2017 | 39.3% | (0.72) |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 45.8% | 1.95 |
| Mar 2026 | 43.9% | 0.08 |
| Dec 2025 | 43.8% | (0.42) |
| Sep 2025 | 44.2% | (0.91) |
| 42 more quarters | Free account |
Against its own ten years
Low 39.3%
High 44.6%
Ten-year median
43.2%
Current reading's percentile
92
Gross margin against peers
| Company | Gross margin |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.9% |
| PEN Penumbra, Inc. compare | 67.8% |
| DXCM DexCom, Inc. compare | 62.5% |
| BIO Bio-Rad Laboratories, Inc. compare | 51.9% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 51.9% |
| PHG Koninklijke Philips N.V. compare | 45.9% |
| STE STERIS plc | 44.4% |
| GEHC GE HealthCare Technologies Inc. compare | 39.5% |
| Medical Devices industry median | 56.0% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement